Author

Cassandra E. Thompson

Gladstone InstitutesORCID 0000-0001-6273-8113Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Joshua GlazieriD· 2 shared Leor S. WeinbergeriD· 2 shared Benjamin MartiniD· 1 shared Daved H. FremontiD· 1 shared Elizabeth J. TanneriD· 1 shared Hongming MaiD· 1 shared Hye-In Son· 1 shared James L. RileyiD· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSynthetic Biology

Joshua GlazierORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintApr 22, 2026

CD164 is an endolysosomal host factor for entry of Clade A New World Arenaviruses

Cassandra E. Thompson, Tomasz Kaszuba, Rita M. Meganck…·Sean P. J. Whelan

The paper identifies CD164 as an endolysosomal receptor for clade A New World arenaviruses, expanding the receptor switching paradigm observed in Old World arenaviruses.

DOI 10.64898/2026.04.21.719929

genetic perturbation / CRISPRhost-pathogen & immune response

𝕏 PostBluesky

Synthetic BiologymBioPeer-reviewedJan 18, 2021

RanDeL-seq: A high-throughput method to map viral cis- and trans-acting elements

Timothy Notton, Joshua Glazier, Victoria R. Saykally…·Leor S. Weinberger

RanDeL-seq maps viral cis- and trans-acting elements by generating and screening high-throughput deletion mutants, revealing critical regions in HIV-1 and ZIKV.

8 citations

experimental assay

𝕏 PostBluesky

Synthetic BiologybioRxivPreprintOct 30, 2019

Discovery and Engineering of a Therapeutic Interfering Particle (TIP): a combination self-renewing antiviral

Elizabeth J. Tanner, Seungyong Jung, Joshua Glazier…·Leor S. Weinberger

This paper discovers and engineers an HIV-1 Therapeutic Interfering Particle (TIP) that suppresses viral replication and protects CD4+ T cells in humanized mice.

6 citations

humanexperimental assay

𝕏 PostBluesky